Dr. Brittany Winstead, PharmD, RPh
BHC 40 Under 40 | Class of 2026 | At the Helm
R&D Global Oncology, Integrated Evidence, Value Access & Brand Strategy | AbbVie | Chicago, IL
Dr. Brittany Winstead is a pharmaceutical leader who combines clinical expertise with strategic innovation to advance patient-centered value across oncology and immunology.
At AbbVie, she leads integrated brand and value access strategies focused on redefining the standard of care for solid tumor cancers.
The Journey
Her journey into healthcare was shaped by her role within her family and community.
"I saw firsthand the gaps in access and understanding, and I felt a responsibility to bridge that."
Her experience working as a pharmacist in a free clinic further deepened that purpose and continues to ground her work today.
What This Recognition Means
For Dr. Winstead, this recognition reflects both individual contribution and a shared commitment to advancing equity and representation.
It reinforces the importance of ensuring that innovation and access remain connected.
What’s Next
She is focused on translating breakthrough science into real-world impact for patients facing serious and underserved conditions.
Becoming a mother has strengthened her sense of urgency and reinforced her commitment to ensuring that innovation reaches those who need it most.
"Stay grounded in the people you serve..."
Dr. Winstead’s work reflects a clear focus on impact. Innovation only matters when it reaches the people it is meant to serve.
Connect
Instagram: @dr.winstead
LinkedIn: Dr. Brittany Winstead
----
The BHC 40 Under 40 Class of 2026 honors the next generation of healthcare leaders reshaping how care is built, delivered, and experienced. Honorees will be celebrated at the Black Health Ball on June 27, 2026.